USD 7.07
(1.02%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 1.84 Billion USD | 10.8% |
2022 | 1.66 Billion USD | 20.28% |
2021 | 1.38 Billion USD | 96.61% |
2020 | 703.13 Million USD | 90.63% |
2019 | 368.84 Million USD | 27.55% |
2018 | 289.17 Million USD | 68.46% |
2017 | 171.65 Million USD | 88.25% |
2016 | 91.18 Million USD | 61.84% |
2015 | 56.34 Million USD | 67.69% |
2014 | 33.59 Million USD | 113.73% |
2013 | 15.72 Million USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 357.82 Million USD | 1.16% |
2024 Q3 | 460.76 Million USD | 28.77% |
2024 Q1 | 353.7 Million USD | -24.28% |
2023 Q1 | 439.13 Million USD | -2.16% |
2023 Q3 | 474.27 Million USD | 2.69% |
2023 Q2 | 461.86 Million USD | 5.18% |
2023 FY | 1.84 Billion USD | 10.8% |
2023 Q4 | 467.1 Million USD | -1.51% |
2022 Q3 | 425.78 Million USD | 3.87% |
2022 Q1 | 378.32 Million USD | -0.24% |
2022 FY | 1.66 Billion USD | 20.28% |
2022 Q4 | 448.83 Million USD | 5.41% |
2022 Q2 | 409.9 Million USD | 8.35% |
2021 FY | 1.38 Billion USD | 96.61% |
2021 Q2 | 342.86 Million USD | 11.42% |
2021 Q3 | 352.61 Million USD | 2.84% |
2021 Q4 | 379.25 Million USD | 7.55% |
2021 Q1 | 307.71 Million USD | 18.18% |
2020 FY | 703.13 Million USD | 90.63% |
2020 Q4 | 260.37 Million USD | 41.44% |
2020 Q3 | 184.08 Million USD | 22.52% |
2020 Q2 | 150.25 Million USD | 38.59% |
2020 Q1 | 108.41 Million USD | 7.2% |
2019 Q4 | 101.13 Million USD | 6.27% |
2019 Q2 | 88.64 Million USD | 5.66% |
2019 FY | 368.84 Million USD | 27.55% |
2019 Q1 | 83.89 Million USD | 1.43% |
2019 Q3 | 95.17 Million USD | 7.36% |
2018 Q4 | 82.71 Million USD | 7.71% |
2018 Q2 | 66.87 Million USD | 6.51% |
2018 Q3 | 76.79 Million USD | 14.83% |
2018 FY | 289.17 Million USD | 68.46% |
2018 Q1 | 62.78 Million USD | 15.37% |
2017 Q3 | 51.9 Million USD | 50.18% |
2017 Q1 | 30.75 Million USD | 12.36% |
2017 FY | 171.65 Million USD | 88.25% |
2017 Q2 | 34.56 Million USD | 12.37% |
2017 Q4 | 54.42 Million USD | 4.85% |
2016 Q1 | 18.94 Million USD | 17.23% |
2016 FY | 91.18 Million USD | 61.84% |
2016 Q4 | 27.37 Million USD | 8.33% |
2016 Q3 | 25.26 Million USD | 28.94% |
2016 Q2 | 19.59 Million USD | 3.44% |
2015 Q4 | 16.16 Million USD | 4.37% |
2015 Q2 | 13.49 Million USD | 20.37% |
2015 Q1 | 11.2 Million USD | 22.37% |
2015 Q3 | 15.48 Million USD | 14.79% |
2015 FY | 56.34 Million USD | 67.69% |
2014 Q2 | 8.26 Million USD | 11.27% |
2014 Q4 | 9.15 Million USD | 4.62% |
2014 Q1 | 7.42 Million USD | 0.0% |
2014 FY | 33.59 Million USD | 113.73% |
2014 Q3 | 8.75 Million USD | 5.95% |
2013 FY | 15.72 Million USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Phreesia, Inc. | 201.74 Million USD | -813.224% |
Accuray Incorporated | 143.12 Million USD | -1187.291% |
Align Technology, Inc. | 2.72 Billion USD | 32.269% |
Elevance Health Inc. | 47.01 Billion USD | 96.081% |
AxoGen, Inc. | 127.87 Million USD | -1340.781% |
Boston Scientific Corporation | 9.84 Billion USD | 81.294% |
CVS Health Corporation | 54.43 Billion USD | 96.615% |
Cardinal Health, Inc. | 7.41 Billion USD | 75.15% |
Centene Corporation | 153.99 Billion USD | 98.804% |
DaVita Inc. | 3.82 Billion USD | 51.775% |
HCA Healthcare, Inc. | 55.06 Billion USD | 96.654% |
Hologic, Inc. | 2.23 Billion USD | 17.67% |
Humana Inc. | 106.44 Billion USD | 98.269% |
IDEXX Laboratories, Inc. | 2.18 Billion USD | 15.872% |
Laboratory Corporation of America Holdings | 3.36 Billion USD | 45.247% |
Masimo Corporation | 1 Billion USD | -83.596% |
McKesson Corporation | 12.58 Billion USD | 85.359% |
Patterson Companies, Inc. | 1.38 Billion USD | -33.483% |
Quest Diagnostics Incorporated | 2.96 Billion USD | 37.778% |
ResMed Inc. | 2.6 Billion USD | 29.378% |
Henry Schein, Inc. | 3.65 Billion USD | 49.538% |
Universal Health Services, Inc. | 1.17 Billion USD | -56.748% |
Veeva Systems Inc. | 1.68 Billion USD | -9.251% |
Baxter International Inc. | 4.97 Billion USD | 62.967% |
Becton, Dickinson and Company | 8.82 Billion USD | 79.118% |
Intuitive Surgical, Inc. | 4.72 Billion USD | 61.045% |
Danaher Corporation | 14.12 Billion USD | 86.96% |
Stryker Corporation | 13.05 Billion USD | 85.891% |
Medtronic plc | 21.27 Billion USD | 91.339% |